Enochian Biosciences Inc
Change company Symbol lookup
Select an option...
ENOB Enochian Biosciences Inc
UGRO Urban-Gro Inc
ACIU AC Immune SA
KPRX Kiora Pharmaceuticals Inc
ATIF ATIF Holdings Ltd
BHR Braemar Hotels & Resorts Inc
QTEKW QualTek Services Equity Warrant Exp 14th Feb 2027 *W EXP 02/14/2027
ALR Alerislife Inc
CCEP Coca-Cola Europacific Partners PLC
QQQ Invesco QQQ Trust
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Enochian BioSciences Inc. is a pre-clinical stage biotechnology company. The Company uses its cell, gene and immune therapy technologies for the treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, as well as to provide cancer remission in some of the deadliest cancers. The Company’s product candidates include ENOB-HV-01, an autologous transplant with genetically modified cells; ENOB-HV-11 and ENOB-HV-12, preventive and therapeutic vaccines; ENOB-HV-21, immunotherapy with allogeneic NK/GDT cells; ENOB-HV-31, in Vivo gene therapy; ENOB-HB-01, potential cure for HBV; ENOB-CV-01, Aerosol/Inhaled treatment potentially for all Coronaviruses that cause human disease; ENOB-CV-11, Aerosol/Inhaled prophylaxis potentially for all coronaviruses that cause human disease; ENOB-FL-01 Aerosol/Inhaled treatment potentially for all influenza viruses; and ENOB-FL-11, Aerosol/Inhaled prophylaxis potentially for all influenza viruses.

Closing Price
$2.45
Day's Change
-0.11 (-4.30%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.52
Day's Low
2.40
Volume
(Light)
Volume:
38,978

10-day average volume:
94,447
38,978
  • Prev Close
    2.56
  • Today's Open
    2.49
  • Day's Range
    2.40-2.52
  • Avg Vol (10-day)
    94.4K
  • Last (time)
    4:00p ET 08/17/22
  • Last (size)
    100
  • 52-Wk Range
    1.42 - 13.78
    LowHigh
  • (12/01/21 - 07/05/22)
    72.54%
  • 115.3%
  • Market Cap
    129.7M
  • Shares Outstanding
    52.9M
  • -0.80
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 4.52
  • (% of float 07/29/22)
    8.72

Latest News

August 17, 2022
7:22 pm ET
Newsfile
5:52 pm ET
Newsfile
4:30 pm ET
Newsfile
3:00 pm ET
Accesswire
2:00 pm ET
Globe Newswire
12:32 pm ET
Accesswire
12:16 pm ET
Globe Newswire
12:00 pm ET
PR Newswire
10:00 am ET
Accesswire
9:11 am ET
Newsfile
9:00 am ET
PR Newswire
5:45 am ET
PR Newswire
August 16, 2022
7:44 pm ET
Newsfile
6:16 pm ET
Newsfile
5:48 pm ET
Accesswire
3:54 pm ET
Globe Newswire
12:03 pm ET
Accesswire
11:00 am ET
Accesswire
11:00 am ET
Globe Newswire
9:30 am ET
Accesswire
9:01 am ET
Newsfile
5:45 am ET
PR Newswire
August 15, 2022
10:30 pm ET
Newsfile
9:00 pm ET
Globe Newswire
8:15 pm ET
BusinessWire
7:15 pm ET
PR Newswire
6:42 pm ET
Accesswire
5:42 pm ET
Newsfile
1:35 pm ET
Accesswire
1:00 pm ET
Globe Newswire
9:16 am ET
Accesswire
8:55 am ET
Newsfile
5:45 am ET
PR Newswire
August 14, 2022
3:48 pm ET
Accesswire
1:26 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.